The Automated Infusion Systems Market is expanding as healthcare providers seek more accurate and efficient ways to manage medication delivery. The market was valued at USD 3.6 billion in 2024 and is projected to reach USD 6.5 billion by 2035, growing at a 5.4% CAGR during 2026–2035.

Smart technologies are becoming central to infusion system development, with AI, IoT, wireless connectivity, and integrated software improving monitoring and dosage control. These features are helping healthcare facilities build more connected and responsive medication delivery workflows.

Smart infusion pumps are expected to lead the product segment, while syringe pumps, volumetric pumps, and patient-controlled analgesia pumps serve different clinical requirements. Chemotherapy is a major application, followed by anesthesia, pain management, diabetes management, and nutrition therapy.

Hospitals remain the primary end-use environment, while home care, ambulatory surgery centers, and specialty clinics are creating additional demand. North America leads the regional market, while Asia-Pacific is showing strong potential as healthcare investment and access to advanced medical technologies increase.

Future opportunities are emerging through EHR interoperability, telehealth connectivity, remote monitoring, and predictive analytics. User-friendly infusion devices designed for home healthcare could also support broader adoption as more treatment shifts toward outpatient and home-based settings.